Paul Tudor Jones Vanda Pharmaceuticals Inc. Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 24,618 shares of VNDA stock, worth $117,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,618

Previous 15,438 59.46%

Holding current value

$117,181

Previous $72,000 62.5%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.41 - $5.46 $40,483 - $50,122	9,180 Added 59.46%	24,618 $117,000
Q3 2024 Nov 14, 2024	BUY	$4.61 - $6.34 $71,169 - $97,876	15,438 New	15,438 $72,000
Q1 2024 May 15, 2024	BUY	$3.47 - $4.61 $356,119 - $473,115	102,628 Added 281.85%	139,040 $571,000
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $123,072 - $166,766	36,412 New	36,412 $153,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $73,783 - $117,710	10,740 New	10,740 $79,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $300,173 - $381,745	-32,242 Reduced 32.78%	66,114 $721,000
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $334,370 - $510,501	30,846 Added 45.69%	98,356 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $779,165 - $1.05 Million	49,660 Added 278.21%	67,510 $1.06 Million
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $269,699 - $373,713	-17,570 Reduced 49.6%	17,850 $306,000
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $311,576 - $426,607	-19,833 Reduced 35.89%	35,420 $762,000
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $462,963 - $699,619	34,498 Added 166.22%	55,253 $830,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $117,474 - $166,051	-12,024 Reduced 36.68%	20,755 $273,000
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $63,189 - $81,495	6,780 Added 26.08%	32,779 $317,000
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $807,682 - $1.01 Million	-83,611 Reduced 76.28%	25,999 $297,000
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $156,090 - $349,641	20,812 Added 23.44%	109,610 $1.14 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $552,383 - $779,493	-44,619 Reduced 33.44%	88,798 $1.46 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $5,840 - $7,516	476 Added 0.36%	133,417 $1.77 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $492,831 - $694,829	36,861 Added 38.36%	132,941 $1.87 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $656,951 - $1.16 Million	37,348 Added 63.59%	96,080 $1.77 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $637,486 - $1.06 Million	33,605 Added 133.74%	58,732 $1.54 Million
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $1.2 Million - $1.51 Million	-65,564 Reduced 72.29%	25,127 $577,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $283,254 - $388,840	20,305 Added 28.85%	90,691 $1.73 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $719,556 - $1.03 Million	51,214 Added 267.13%	70,386 $1.19 Million
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $58,878 - $82,934	4,582 Added 31.41%	19,172 $291,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $224,686 - $275,021	14,590	14,590 $261,000

Others Institutions Holding VNDA

# of Institutions

155

Shares Held

43.7M

Call Options Held

33.8K

Put Options Held

28.7K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $269M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account